Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer

Abstract

Reduced expression of serum exosomal miR-4772-3p is a prognostic biomarker for tumor recurrence in stage II and stage III colon cancer patients. The predictive value of this marker for response to FOLFOX adjuvant therapy needs further investigation.